Drugs for Malaria Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Drugs for Malaria market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.0% during the forecast period.

    This report presents the market size and development trends by detailing the Drugs for Malaria market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Drugs for Malaria market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Drugs for Malaria industry and will help you to build a panoramic view of the industrial development.

    Drugs for Malaria Market, By Type:

    • Aryl Aminoalcohol Compounds

    • Antifolate Compounds

    • Artemisinin Compounds

    Drugs for Malaria Market, By Application:

    • Prevention

    • Treatment

    • Others

    Some of the leading players are as follows:

    • Cipla

    • Mylan Labs

    • GlaxoSmithKline

    • Sanofi Aventis

    • IPCA Laboratories

    • Ajanta Pharma

    • Guilin Pharmaceutical

    • Roche

    • Novartis

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Drugs for Malaria Market

    • 1.3 Market Segment by Type

      • 1.3.1 Aryl Aminoalcohol Compounds

      • 1.3.2 Antifolate Compounds

      • 1.3.3 Artemisinin Compounds

    • 1.4 Market Segment by Application

      • 1.4.1 Prevention

      • 1.4.2 Treatment

      • 1.4.3 Others

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Drugs for Malaria Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Drugs for Malaria Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Drugs for Malaria Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Drugs for Malaria Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Drugs for Malaria Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Drugs for Malaria by Major Types

      • 3.4.1 Aryl Aminoalcohol Compounds

      • 3.4.2 Antifolate Compounds

      • 3.4.3 Artemisinin Compounds

    4 Segmentation of Drugs for Malaria Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Drugs for Malaria by Major End-Users

      • 4.4.1 Prevention

      • 4.4.2 Treatment

      • 4.4.3 Others

    5 Market Analysis by Major Regions

    • 5.1 Global Drugs for Malaria Production Analysis by Top Regions

    • 5.2 Global Drugs for Malaria Consumption Analysis by Top Regions

    • 5.3 Global Drugs for Malaria Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Drugs for Malaria Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Drugs for Malaria Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Drugs for Malaria Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Drugs for Malaria Production, Import, Consumption and Export Analysis

    6 Product Circulation of Drugs for Malaria Market among Top Countries

    • 6.1 Top 5 Export Countries in Drugs for Malaria Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Drugs for Malaria Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Drugs for Malaria Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Drugs for Malaria Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Drugs for Malaria Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Drugs for Malaria Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Drugs for Malaria Landscape Analysis

    • 7.1 North America Drugs for Malaria Landscape Analysis by Top Countries

      • 7.1.1 United States Drugs for Malaria Market Volume and Growth Rate

      • 7.1.2 Canada Drugs for Malaria Market Volume and Growth Rate

      • 7.1.3 Mexico Drugs for Malaria Market Volume and Growth Rate

    8. Europe Drugs for Malaria Landscape Analysis

    • 8.1 Europe Drugs for Malaria Landscape Analysis by Major Types

    • 8.2 Europe Drugs for Malaria Landscape Analysis by Major End-Users

    • 8.3 Europe Drugs for Malaria Landscape Analysis by Top Countries

      • 8.3.1 Germany Drugs for Malaria Market Volume and Growth Rate

      • 8.3.2 UK Drugs for Malaria Market Volume and Growth Rate

      • 8.3.3 France Drugs for Malaria Market Volume and Growth Rate

      • 8.3.4 Italy Drugs for Malaria Market Volume and Growth Rate

      • 8.3.5 Spain Drugs for Malaria Market Volume and Growth Rate

      • 8.3.6 Belgium Drugs for Malaria Market Volume and Growth Rate

      • 8.3.7 Poland Drugs for Malaria Market Volume and Growth Rate

      • 8.3.8 Russia Drugs for Malaria Market Volume and Growth Rate

      • 8.3.9 Turkey Drugs for Malaria Market Volume and Growth Rate

      • 8.3.10 Netherlands Drugs for Malaria Market Volume and Growth Rate

      • 8.3.11 Portugal Drugs for Malaria Market Volume and Growth Rate

      • 8.3.12 Denmark Drugs for Malaria Market Volume and Growth Rate

      • 8.3.13 Finland Drugs for Malaria Market Volume and Growth Rate

      • 8.3.14 Iceland Drugs for Malaria Market Volume and Growth Rate

      • 8.3.15 Norway Drugs for Malaria Market Volume and Growth Rate

      • 8.3.16 Sweden Drugs for Malaria Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Drugs for Malaria Landscape Analysis

    • 9.1 Asia Pacific Drugs for Malaria Landscape Analysis by Top Countries

      • 9.1.1 China Drugs for Malaria Market Volume and Growth Rate

      • 9.1.2 Japan Drugs for Malaria Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Drugs for Malaria Market Volume and Growth Rate

      • 9.1.4 India Drugs for Malaria Market Volume and Growth Rate

      • 9.1.5 ASEAN Drugs for Malaria Market Volume and Growth Rate

      • 9.1.6 South Korea Drugs for Malaria Market Volume and Growth Rate

    10 LAMEA Drugs for Malaria Landscape Analysis

    • 10.1 LAMEA Drugs for Malaria Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Drugs for Malaria Market Volume and Growth Rate

      • 10.1.2 Brazil Drugs for Malaria Market Volume and Growth Rate

      • 10.1.3 North Africa Drugs for Malaria Market Volume and Growth Rate

      • 10.1.4 South Africa Drugs for Malaria Market Volume and Growth Rate

      • 10.1.5 Argentina Drugs for Malaria Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Cipla

      • 11.1.1 Cipla Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Mylan Labs

      • 11.2.1 Mylan Labs Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 GlaxoSmithKline

      • 11.3.1 GlaxoSmithKline Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Sanofi Aventis

      • 11.4.1 Sanofi Aventis Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 IPCA Laboratories

      • 11.5.1 IPCA Laboratories Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Ajanta Pharma

      • 11.6.1 Ajanta Pharma Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Guilin Pharmaceutical

      • 11.7.1 Guilin Pharmaceutical Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Roche

      • 11.8.1 Roche Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Novartis

      • 11.9.1 Novartis Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 118 Figures and 161 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Aryl Aminoalcohol Compounds

    • Figure Market Size and Growth Rate of Antifolate Compounds

    • Figure Market Size and Growth Rate of Artemisinin Compounds

    • Figure Market Size and Growth Rate of Prevention

    • Figure Market Size and Growth Rate of Treatment

    • Figure Market Size and Growth Rate of Others

    • Figure North America Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure United States Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure UK Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure France Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure China Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure India Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Drugs for Malaria Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Drugs for Malaria Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Drugs for Malaria

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Drugs for Malaria by Different Types from 2014 to 2026

    • Table Consumption Share of Drugs for Malaria by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Aryl Aminoalcohol Compounds

    • Figure Market Size and Growth Rate of Antifolate Compounds

    • Figure Market Size and Growth Rate of Artemisinin Compounds

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Drugs for Malaria by Different End-Users from 2014 to 2026

    • Table Consumption Share of Drugs for Malaria by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Prevention

    • Figure Market Size and Growth Rate of Treatment

    • Figure Market Size and Growth Rate of Others

    • Table Global Drugs for Malaria Production by Major Regions

    • Table Global Drugs for Malaria Production Share by Major Regions

    • Table Global Drugs for Malaria Consumption by Major Regions

    • Table Global Drugs for Malaria Consumption Share by Major Regions

    • Table North America Drugs for Malaria Production, Import, Consumption and Export Analysis

    • Table Europe Drugs for Malaria Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Drugs for Malaria Production, Import, Consumption and Export Analysis

    • Table LAMEA Drugs for Malaria Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Drugs for Malaria Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Drugs for Malaria Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Drugs for Malaria Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Drugs for Malaria Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Drugs for Malaria Consumption by Major Countries from 2014 to 2026

    • Table North America Drugs for Malaria Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Drugs for Malaria Consumption Share by Major Countries in 2014

    • Figure North America Drugs for Malaria Consumption Share by Major Countries in 2018

    • Figure North America Drugs for Malaria Consumption Share by Major Countries in 2026

    • Figure United States Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Drugs for Malaria Consumption by Types from 2014 to 2026

    • Table Europe Drugs for Malaria Consumption Share by Types from 2014 to 2026

    • Table Europe Drugs for Malaria Consumption by End-Users from 2014 to 2026

    • Table Europe Drugs for Malaria Consumption Share by End-Users from 2014 to 2026

    • Table Europe Drugs for Malaria Consumption by Major Countries from 2014 to 2026

    • Table Europe Drugs for Malaria Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure France Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Drugs for Malaria Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Drugs for Malaria Consumption Share by Major Countries from 2014 to 2026

    • Figure China Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure India Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Drugs for Malaria Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Drugs for Malaria Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Drugs for Malaria Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla

    • Figure Sales and Growth Rate Analysis of Cipla

    • Figure Revenue and Market Share Analysis of Cipla

    • Table Product and Service Introduction of Cipla

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Labs

    • Figure Sales and Growth Rate Analysis of Mylan Labs

    • Figure Revenue and Market Share Analysis of Mylan Labs

    • Table Product and Service Introduction of Mylan Labs

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Aventis

    • Figure Sales and Growth Rate Analysis of Sanofi Aventis

    • Figure Revenue and Market Share Analysis of Sanofi Aventis

    • Table Product and Service Introduction of Sanofi Aventis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IPCA Laboratories

    • Figure Sales and Growth Rate Analysis of IPCA Laboratories

    • Figure Revenue and Market Share Analysis of IPCA Laboratories

    • Table Product and Service Introduction of IPCA Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ajanta Pharma

    • Figure Sales and Growth Rate Analysis of Ajanta Pharma

    • Figure Revenue and Market Share Analysis of Ajanta Pharma

    • Table Product and Service Introduction of Ajanta Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guilin Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Guilin Pharmaceutical

    • Figure Revenue and Market Share Analysis of Guilin Pharmaceutical

    • Table Product and Service Introduction of Guilin Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.